CSIMarket
 


United Cannabis Corp  (CNAB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CNAB's Operating Income Growth by Quarter and Year

United Cannabis's Operating Income results by quarter and year




CNAB Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -2.69 -1.90 0.08
III Quarter September -6.92 -1.46 -0.65 -0.11
II Quarter June -1.30 -10.41 -2.12 -0.06
I Quarter March -1.68 -6.70 -0.52 -
FY   -9.90 -21.26 -5.19 -0.09



CNAB Operating Income third quarter 2019 Y/Y Growth Comment
United Cannabis Corp in the third quarter recorded Operating Loss of $ -6.92 millions.

According to the results reported in the third quarter, United Cannabis Corp achieved the best Operating Income growth in Biotechnology & Drugs industry. While United Cannabis Corp' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


CNAB Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
United Cannabis's third quarter 2019 Operating Income $ -6.92 millions CNAB's Income Statement
United Cannabis's third quarter 2018 Operating Income $ -1.46 millions Quarterly CNAB's Income Statement
New: More CNAB's historic Operating Income Growth >>


CNAB Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

United Cannabis's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CNAB's III. Quarter Q/Q Operating Income Comment
Current results of -6.92 millions by United Cannabis Corp appear even more unfavourable if you take a look at Operating Loss -1.30 millions a quarter before.

Within Biotechnology & Drugs industry United Cannabis Corp achieved highest sequential Operating Income growth. While United Cannabis's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CNAB's III. Quarter Q/Q Operating Income Comment
III. Quarter 2019 accomplishment of -6.92 millions by United Cannabis Corp look even less good considering the Operating Loss -1.30 millions in the second quarter.

Within Biotechnology & Drugs industry United Cannabis Corp achieved highest sequential Operating Income growth. While United Cannabis's Operating Income growth quarter on quarter, overall rank is .


United Cannabis's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
Cumulative Operating Income 12 Months Ending $ -12.59 $ -7.12 $ -16.24 $ -21.25 $ -20.47
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


United Cannabis Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


United Cannabis Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Drugs Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CNAB's Operating Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CNAB's Competitors
Operating Income Growth for United Cannabis's Suppliers
Operating Income Growth for CNAB's Customers

You may also want to know
CNAB's Annual Growth Rates CNAB's Profitability Ratios CNAB's Asset Turnover Ratio CNAB's Dividend Growth
CNAB's Roe CNAB's Valuation Ratios CNAB's Financial Strength Ratios CNAB's Dividend Payout Ratio
CNAB's Roa CNAB's Inventory Turnover Ratio CNAB's Growth Rates CNAB's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2019
Molecular Templates, Inc.  653.80 %$ 653.802 millions
Electromed, Inc.  577.90 %$ 577.895 millions
Alr Technologies Inc.  404.36 %$ 404.357 millions
Dynatronics Corp  353.17 %$ 353.174 millions
Incyte Corp  331.62 %$ 331.621 millions
Dexcom, Inc.  302.88 %$ 302.878 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BDCO's Profile

Stock Price

BDCO's Financials

Business Description

Fundamentals

Charts & Quotes

BDCO's News

Suppliers

BDCO's Competitors

Customers & Markets

Economic Indicators

BDCO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071